The company claims it is creating cutting-edge treatments and diagnostics for serious, life-threatening, and debilitating disorders. The company says it is making significant investments in the creation of techniques for creating medications without using animals, such as computer simulations or strategies like organ on chip or organoids. These are systems containing engineered or natural miniature tissues grown inside microfluidic chips.
"We test thousands of known drugs, on hundreds of different 'patients-on-a-chip,' and use the data that is generated to train the AI to recognize which drug is safe in the human body," said Bentwich. Real-time nanosensors track how each of these miniature organs reacts to medications, and artificial intelligence is used to analyze the vast amounts of data produced.
"In other words, it is an artificial replica of a physiologically interacting human tissue or organ system in a cell culture environment."